TrialInternational journal of hematology2018

Lower glomerular filtration rate predicts increased hepatic and mucosal toxicity in myeloma patients treated with high-dose melphalan.

Masaharu Tamaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.